Esmolol cardioplegia in unstable coronary revascularisation patients: A randomised clinical trial

Acta Anaesthesiologica Scandinavica

Volumn 44, Issue 6, 2000, Pages 727-732

  Rinne, T ^a   Harmoinen, A ^a   Kaukinen, S ^a  

^a TAMPERE UNIVERSITY HOSPITAL   (Finland)

Author keywords

Adrenergic beta antagonists; Blood cardioplegia; Cardioplegic solutions; Contractile proteins; Coronary artery bypass; Esmolol; Randomized clinical trial; Troponin I

Indexed keywords

ACETYLSALICYLIC ACID; CREATINE KINASE MB; ESMOLOL; GLYCERYL TRINITRATE; ISOFLURANE; LACTIC ACID; LOW MOLECULAR WEIGHT HEPARIN; MIDAZOLAM; MYOGLOBIN; PANCURONIUM; SODIUM CHLORIDE; SUFENTANIL; TROPONIN I;

ADULT; AGED; ARTICLE; CARDIOPLEGIA; CARDIOPULMONARY BYPASS; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; CREATINE KINASE BLOOD LEVEL; DOUBLE BLIND PROCEDURE; ELECTROCARDIOGRAM; FEMALE; FORWARD HEART FAILURE; HEART ARREST; HEART INFARCTION; HEART MUSCLE ISCHEMIA; HEART MUSCLE REVASCULARIZATION; HEART PROTECTION; HEART RHYTHM; HUMAN; MALE; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; UNSTABLE ANGINA PECTORIS;

ADRENERGIC BETA-ANTAGONISTS; AGED; CARDIOPLEGIC SOLUTIONS; CORONARY ARTERY BYPASS; CREATINE KINASE; DOUBLE-BLIND METHOD; ELECTROCARDIOGRAPHY; FEMALE; HUMANS; LACTIC ACID; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; MYOCARDIAL REVASCULARIZATION; MYOGLOBIN; POSTOPERATIVE COMPLICATIONS; PROPANOLAMINES; PROSPECTIVE STUDIES; TROPONIN;

EID: 0034125105     PISSN: 00015172     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1399-6576.2000.440611.x     Document Type: Article

References (26)

1. 1. Sum CY, Yacobi A, Kartzinel R, Stampfli H, Davis CS, Lai CM. Kinetics of esmolol, an ultra-short-acting beta blocker, and of its major metabolite. Clin Pharmacol Ther 1983: 34: 427-434.
2. 2. Girard D, Shulman BJ, Thys DM, Mindich Bp, Mikula SK, Kaplan JA. The safety and efficacy of esmolol during myocardial revascularization. Anesthesiology 1986: 65: 157-164.
3. 3. Cork RC, Kramer TH, Dreischmeier B, Behr S, DiNardo JA. The effect of esmolol given during cardiopulmonary bypass. Anesth Analg 1995: 80: 28-40.
4. 4. Pirk J, Kellovský P. An alternative to cardioplegia. Ann Thorac Surg 1995: 60: 464-465.
5. 5. Sweeney MS, Frazier OH. Device-supported myocardial revascularization: Safe help for sick hearts. Ann Thorac Surg 1992: 54: 1065-1070.
6. 6. Borowski A, Korb H. Myocardial protection by pressure-and volume-controlled continuous hypothermic coronary perfusion (PVC-CONTHY-CAP) in combination with ultra-short beta-blockade and nitroglycerine. Thorac Cardiovasc Surg 1997: 45: 51-54.
7. 7. Mehlhorn U. Improved myocardial protection using continuous coronary perfusion with normothermic blood and beta-blockade with esmolol. Thorac Cardiovasc Surg 1997: 45: 224-231.
8. 8. Borowski A, Raji MR, Eichstaedt HC, Korb H. Myocardial protection by pressure-and volume-controlled continuous hypothermic coronary perfusion in combination with esmolol and nitroglycerine for correction of congenital heart defects in pediatric risk patients. Eur J Cardiothorac Surg 1998: 14: 243-249.
9. 9. Al-Shanableh J, Hylani M, Hammadi T. Esmolol added to crystalloid cardioplegia. EACTA Abstract Book 1995: G3.
10. 10. Adams JE, Sicard GA, Allen BT, Bridwell KH, Lenke LG, Dávila-Román VG et al. Diagnosis of perioperarive myocardial infarction with measurement of cardiac troponin-I. N Engl J Med 1994: 330: 670-674.
11. 11. Mair J, Larue C, Mair P, Balogh D, Calzolari C, Puschendorf B. Use of cardiac troponin I to diagnose perioperative infarction in coronary artery bypass grafting. Clin Chem 1994: 40: 2066-2070.
12. 12. Etievent J-P, Chocron S, Toubin G, Taberlet C, Alwan K, Clement F et al. Use of cardiac troponin I as a marker of perioperative myocardial ischemia. Ann Thorac Surg 1995: 59: 1192-1194.
13. 13. Jaquet L, Noirhomme P, El Khoury G, Goenen M, Philippe M, Col J et al. Cardiac troponin-I as an early marker of myocardial damage after coronary bypass surgery. Eur J Cardiothorac Surg 1998: 13: 378-384.
14. 14. Gensini GF, Fusi C, Conti AA, Calamai GC, Montesi GF, Galanti G et al. Cardiac troponin I and Q-wave perioperative myocardial infarction after bypass surgery. Crit Care Med 1998: 26: 1986-1990.
15. 15. Pichon H, Chocron S, Alwan K, Toubin G, Kaili D, Falcoz P et al. Crystalloid versus cold blood cardioplegia and cardiac troponin I release. Circulation 1997: 96: 316-320.
16. 16. Birdi I, Angelini GD, Bryan AJ. Biochemical markers of myocardial injury during cardiac operations. Ann Thorac Surg 1977: 63: 879-884.
17. 17. Nayler WG, Ferrari R, Williams A. Protective effect of pretreatment with verapamil, nifedipine, and propranolol on mitochondrial function in ischemic and reperfused myocardium. Am J Cardiol 1980: 46: 242-248.
18. 18. Reynolds RD, Burmeister WE, Gorkzynski RJ. Effect of propranolol on myocardial infarct size with and without coronary artery reperfusion in the dog. Cardiovasc Res 1981: 15: 411-420.
19. 19. Franson RC, Pang DC, Weglicki WB. Modulation of lipolytic activity in isolated canine cardiac sarcolemma by isoproteronol and propranolol. Biochem Biophys 1979: 90: 956-960.
20. 20. Becker LC, Fortuin NJ, Pitt B. Effect of ischemia and antianginal drugs on the distribution of radioactive microspheres in the canine left ventricle. Circ Res 1971: 28: 263-269.
21. 21. Nayler WG, Fassold E, Ypez C. Pharmacological protection of mitochondrial function in hypoxic heart muscle: effects of verapamil, propranolol, and methylprednisolone. Cardiovasc Res 1978: 12: 152-161.
22. 22. Opie LH, Thomas M. Propranolol and experimental myocardial infarction: substrate effects. Postgrad Med J 1976: 52: 124-132.
23. 23. Frishman WH, Chang CM. Beta-adrenergic blockade in the prevention of myocardial infarction: a new theory. J Hypertens 1991: 9 (Suppl): S31-S34.
24. 24. Röth E, Török B. Effect of the ultra-short acting β-blocker Brevibloc on free-radical-mediated injuries during early reperfusion state. Basic Res Cardiol 1991: 86: 422-433.
25. 25. Shaffer JE, Quon CY, Gorczynski RJ. Beta-adrenoreceptor antagonist potency and pharmacodynamics of ALS-8123, the primary acid metabolite of esmolol. J Cardiovasc Pharmacol 1988: 11: 187-192.
26. 26. Chocron S, Alwan K, Toubin G, Clement F, Kaili D, Taberlet C et al. Crystalloid cardioplegia route of delivery and cardiac troponin I release. Ann Thorac Surg 1996: 62: 481-485.